Coronary artery spasms rare during dobutamine stress echo
(HealthDay) -- The occurrence of coronary artery spasm (CAS) during dobutamine stress echocardiography (DSE) is rare, with a prevalence of 0.4 percent, according to a study published in the March 15 issue of The American Journal of Cardiology.
Nicolas Mansencal, M.D., Ph.D., of the Public-Hospital of Paris in Boulogne, France, and colleagues conducted a prospective review of 2,179 patients over age 18 who underwent DSE from November 2001 to October 2010 to assess the prevalence of coronary artery spasm (CAS) during DSE.
The researchers found ST-segment elevation in 21 patients, all of whom underwent emergency coronary angiography. Significant coronary stenosis was seen in 13 of these patients -- seven with chronic coronary occlusion and six with critical coronary stenosis. No significant coronary stenosis was seen in the remaining eight patients, seven of whom were men, with a mean age of 67 years. There was a 0.4 percent prevalence of CAS during DSE.
"In our experience the prevalence of coronary artery spasm during DSE is 0.4 percent. Interestingly, coronary artery spasm may be considered a side effect of dobutamine or could unmask real vasospastic angina," the authors write.
More information: Abstract
Full Text (subscription or payment may be required)
Copyright © 2012 HealthDay. All rights reserved.
-
Newer cardiac imaging machines effective in detecting coronary artery stenosis
Aug 26, 2008 |
not rated yet |
0
-
Large study illustrates cardiac CT can effectively assess coronary artery disease
Dec 01, 2008 |
not rated yet |
0
-
Coronary CTA: Non-invasive, low cost alternative for 'intermediate risk' patients
Dec 01, 2008 |
not rated yet |
0
-
Family history is strong predictor of obstructive coronary artery disease using CCTA
Mar 14, 2010 |
not rated yet |
0
-
Researchers study outcomes of carotid artery stenting following prior carotid procedure
Nov 14, 2011 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Question of reflection and transmission of TEM wave in normal incidenc
1 hour ago
-
the rudyak-krasnolutski effective potencial
2 hours ago
-
Normal force for a lever model
3 hours ago
-
gravity is std. therefore can we rate a 'mass at height' by watts?
9 hours ago
-
Calculating on-axis elements of a solenoid
21 hours ago
-
latitude & longitude & air pressure
22 hours ago
- More from Physics Forums - Classical Physics
More news stories
Death rates decline for advanced heart failure patients, but outcomes are still not ideal
UCLA researchers examining outcomes for advanced heart-failure patients over the past two decades have found that, coinciding with the increased availability and use of new therapies, overall mortality has decreased and sudden ...
Cardiology
2 hours ago |
not rated yet |
0
Second-generation TAVI device—Lotus Valve—shows good performance in REPRISE II
22 May 2013, Paris, France: The Lotus Valve, a second-generation transcatheter aortic valve implantation (TAVI) device, was successfully implanted in all of the first 60 patients in results from REPRISE II reported at EuroPCR ...
Cardiology
6 hours ago |
not rated yet |
0
Costs to treat stroke in America may double by 2030
Costs to treat stroke are projected to more than double and the number of people having strokes may increase 20 percent by 2030, according to the American Heart Association/American Stroke Association.
Cardiology
May 22, 2013 |
not rated yet |
0
New blood-thinner measures may cut medication errors
Blood thinners are the preferred treatment option to prevent heart attacks, blood clots and stroke, but they are not without risk, and not just because of their side effects. These high-risk drugs, known as anticoagulants, ...
Cardiology
May 22, 2013 |
not rated yet |
0
Registry questions superiority of bivalirudin over heparin
Results from a large observational study reported at EuroPCR 2013 today question whether bivalirudin is superior to heparin in the absence of GPIIb/IIIa blockade, showing similar 30-day mortality in patients with non-ST segment ...
Cardiology
May 22, 2013 |
5 / 5 (1) |
0
Controlling mood through the motions of mitochondria
(Medical Xpress)—Regulating the distribution of power in neurons is done by a system that makes the national electric grid look simple by comparison. Each neuron has several thousand mitochondria confined ...
Future doctors unaware of their obesity bias
Two out of five medical students have an unconscious bias against obese people, according to a new study by researchers at Wake Forest Baptist Medical Center. The study is published online ahead of print in the Journal of ...
WHO: Scientific red tape mars efforts vs. virus
International efforts to combat a new pneumonia-like virus that has now killed 22 people are being slowed by unclear rules and competition for the potentially profitable rights to disease samples, the head ...
Research identifies a way to make cancer cells more responsive to chemotherapy
Breast cancer characterized as "triple negative" carries a poor prognosis, with limited treatment options. In some cases, chemotherapy doesn't kill the cancer cells the way it's supposed to. New research from Western University ...
Mayo Clinic genomic analysis lends insight to prostate cancer
Mayo Clinic researchers have used next generation genomic analysis to determine that some of the more aggressive prostate cancer tumors have similar genetic origins, which may help in predicting cancer progression. The findings ...
Shortage of key drug hampering U.S. efforts to control TB, report says
(HealthDay)—A shortage of a critical tuberculosis drug has hampered the efforts of health departments across the United States to contain the spread of the highly infectious lung disease, federal officials ...
